DEC 16, 2020 7:00 AM PST

The Impact of MBT Sepsityper®: The Lahey Experience

Sponsored by: Bruker Daltonics
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Senior Technologist II, Microbiology Laboratory Lahey Hospital & Medical Center, Burlington, MA
    Biography
      Felicia obtained a Graduate Certificate in Health Service Administration from the University of Lowell, as well as a Bachelor's degree from Northeastern University. She has been employed by Lahey Hospital & Medical Center for the past 29 years, in the Microbiology department. Felicia's current role and responsibilities as Sr. Tech II include the operations of the Bruker MALDI Biotyper® and the MicroScan WalkAway system. The microbiology laboratory at Lahey implemented the Bruker MALDI Biotyper® in 2015, where Felicia has played a key role in the implementation, acceptance and expansion beyond microbial identification direct from overnight positive blood culture. Additional roles and responsibilities include IQCP and QA processes, creating antibiograms, participating in infection control and antibiotic subcommittee meetings, submit CAP surveys, and implement new technologies. Felicia is also currently an inspector for the College of American Pathologists and received a safety award for 2019 calendar year. In 2019 she was a speaker at the Bruker Customer Symposium at ASM in June, and presented as well in the fall at a local microbiology meeting.

    Abstract
    Date:  December 16, 2020
    Time: 7:00am (PST), 10:00am (EST)
     
    During this webinar we will discuss the implementation and impact of the MALDI Biotyper® and the MBT Sepsityper® in the clinical microbiology laboratory at Lahey Hospital and Medical Center. We will learn how the implementation of the MBT Sepsityper® rapid sample preparation impacts time-to-result in the identification of organisms directly isolated from positive blood cultures. The components of the MBT Sepsityper® kit will be explained as well as the length of time needed to identify organisms using both rapid and non-rapid sample preparations. Case studies will illustrate the critical time-to-identification for targeted antimicrobial treatment. The webinar will close with a Q & A session.
     
    Learning Objectives
    • Learn about the benefits of MALDI-TOF technology over traditional microbiology identification methods
    • Understand the difference in workflow and time-to-result between non-rapid and rapid MBT Sepsityper® sample preparation methods
    • How can the MBT Sepsityper® solution affect the treatment of a patient, especially after implementing the rapid sample preparation method

     

    *Lahey Hospital and Medical Center have validated all described non-IVD methods, software, kits and workflows for in-house clinical use.

    FDA clearance for Bruker´s MBT Sepsityper® Kit US IVD is pending.

     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 20, 2021 11:00 AM PDT
    C.E. CREDITS
    APR 20, 2021 11:00 AM PDT
    Date: April 20, 2021 Time: 11:00am (PST), 2:00pm (EST) Identification and confirmation of microbial isolates is crucial in the analysis workflow, providing decision-makers the information...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    DEC 16, 2020 7:00 AM PST

    The Impact of MBT Sepsityper®: The Lahey Experience

    Sponsored by: Bruker Daltonics
    C.E. Credits: P.A.C.E. CE Florida CE

    Specialty

    Microbiology

    Laboratory Testing

    Infectious Disease

    Molecular Diagnostics

    Disease

    Clinical Diagnostics

    Molecular Biology

    Research And Development

    Immunology

    Clinical Medicine

    Health

    Research

    Molecular Genetics

    Biotechnology

    Diagnostics

    Geography

    North America68%

    Asia15%

    Europe11%

    South America2%

    Africa2%

    Registration Source

    Website Visitors67%

    Email Promotions15%

    Labroots Registration (Also interested in)10%

    WAVE Newsletter Promotion5%

    Website Banners2%

    Social Media Promotions1%

    Job Title

    Medical Laboratory Technician21%

    Facility/Department Manager18%

    Lab Management9%

    Student9%

    Executive7%

    Educator/Faculty6%

    Microbiologist6%

    Clinical Laboratory Scientist6%

    Research Scientist4%

    Medical Doctor/Specialist4%

    Scientist3%

    Marketing/Sales3%

    Biologist2%

    Post Doc1%

    Consultant1%

    QC/QA1%

    Pharmacist1%

    Organization

    Hospital28%

    Clinical Laboratory17%

    Academic Institution15%

    Diagnostic Company7%

    Biotech Company4%

    Medical Device Company4%

    Government3%

    Medical Center2%

    Government/public2%

    Research Institute2%

    Life Science Company2%

    Manufacturer - Other2%

    Independent Laboratories2%

    Distribution/sales1%

    Other2%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more